A certain proportion of the adult population has not only white adipose (or fatty) tissue, but also the brown kind. This brown adipose tissue helps to convert sugar and fat into heat. People with brown adipose tissue are better at regulating their body temperature in the winter, and are less likely to suffer from excess weight or diabetes.

An international team of researchers has now discovered that the statin class of pharmaceuticals reduces the formation of brown adipose tissue. Statins are prescribed as a way to reduce the risk of a heart attack since they reduce cholesterol levels in the blood. They are among the most commonly prescribed drugs worldwide.

The authors conducted cell culture experiments, they found out that the biochemical pathway responsible for producing cholesterol plays a central role conversion of white to brown adipose tissue. They also discovered that the key molecule regulating the transformation is the metabolite geranylgeranyl pyrophosphate, and mediated by geranylgeranyltransferases (GGTases), enzymes  catalyzing  geranylgeranylation of small GTP-binding proteins, thereby regulating YAP1/TAZ signaling through F-actin modulation. 

Earlier studies showed that the cholesterol biochemical pathway is also central to the functioning of statins; one of their effects is to reduce the production of geranylgeranyl pyrophosphate. This is why the researchers wanted to know whether statins also impact the formation of brown adipose tissue. And indeed they do, as the scientists have now shown in studies on mice and humans.

One thing the researchers did was study positron emission tomography scans of 8,500 patients. This let them determine whether the person had brown adipose tissue. It was also known whether the patients were taking statins. Evaluating the scans shows that 6 percent of those not taking the medication had brown adipose tissue, but this tissue type was present in only a little over 1 percent of those who were taking statins. The researchers conducted a separate clinical study of 16 people to demonstrate that statins reduce the activity of brown adipose tissue.

Although the study demonstrated that statins have a negative impact, researchers warn against talking them down. "We also have to consider that statins are incredibly important as a way to prevent cardiovascular disease. They save millions of lives around the world, and they are prescribed for a very good reason," the senior author says.

However, statins also have another negative effect: in high doses, they slightly increase some people's risk of developing diabetes - as has been shown in other studies. "It's possible that these two effects - the reduction in brown adipose tissue and the slightly increased risk of diabetes - are related," the senior author says, adding that this question requires further research.

https://www.ethz.ch/en/news-and-events/eth-news/news/2018/12/statins-reduce-brown-adipose-tissue.html

https://linkinghub.elsevier.com/retrieve/pii/S1550413118307368